Pfizer Inc
featured
Stocks closed down 1 percent after the minutes from the last Fed policy setting meeting suggested the central bank could begin tapering bond purchases sooner than the market expects.
» Read More
More
-
CHICAGO, May 23- Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.
-
Baxter International Inc. fell$. 74 or 1.0 percent, to $72.30. Bristol-Myers Squibb Co. rose $2.34 or 5.3 percent, to $46.40. Hospira fell$. 52 or 1.4 percent, to $35.40.
-
Stocks closed down 1 percent after the minutes from the last Fed policy setting meeting suggested the central bank could begin tapering bond purchases sooner than the market expects.
-
Baxter International Inc. rose$. 16 or. 2 percent, to $73.20. Bristol-Myers Squibb Co. rose $3.30 or 7.5 percent, to $47.36. Hospira rose$. 02 or. 1 percent, to $35.94.
-
NEW YORK-- A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. Bank of America Corp. rose 1.4 percent to $13.63 with 88,111,200 shares traded. Barrick Gold Corp. rose 1.8 percent to $19.71 with 16,112,200 shares traded.
-
Baxter International Inc. rose$. 32 or. 4 percent, to $73.36. Bristol-Myers Squibb Co. rose $2.27 or 5.2 percent, to $46.33. Hospira rose$. 21 or. 6 percent, to $36.13.
-
TRENTON, N.J.-- Drugmaker Pfizer Inc. plans to try to sell its controlling stake in its former animal health business, Zoetis Inc., through a voluntary stock exchange with Pfizer shareholders.
-
May 22- Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7 percent discount. Pfizer, the largest U.S. drugmaker, sold Zoetis shares in an initial public offering in February that raised $2.2 billion.
-
May 22- Pfizer Inc said on Wednesday that it would unwind its remaining stake in animal health business Zoetis Inc through an exchange offer in which shareholders can swap Pfizer stock for that of Zoetis at a discount. Giant pharmaceutical maker Pfizer spun off Zoetis shares in an initial public offering in February that raised $2.2 billion.
-
Baxter International Inc. rose$. 10 or. 1 percent, to $73.04. Bristol-Myers Squibb Co. rose$. 30 or. 7 percent, to $44.06. Hospira fell$. 11 or. 3 percent, to $35.92.
-
Stocks closed higher but off their best levels after two Fed officials dampened speculation the central bank was ready to consider "tapering" its bond-buying.
-
In a story May 20 about Pfizer Inc. halting a cancer drug study, The Associated Press erroneously reported the uses of two of the drugmaker's existing cancer medicines. Bosulif is approved for use in certain patients with chronic myelogenous leukemia and Inlyta is for advanced kidney cancer.
-
NEW YORK-- A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. Advanced Micro Devices Inc. fell. 9 percent to $4.07 with 23,047,800 shares traded. Bank of America Corp. fell. 4 percent to $13.46 with 65,492,500 shares traded.
-
Baxter International Inc. fell$. 22 or. 3 percent, to $72.72. Bristol-Myers Squibb Co. fell$. 08 or. 2 percent, to $43.68. Hospira rose$. 12 or. 3 percent, to $36.15.
-
Bristol-Myers Squibb Co. rose$. 25 or. 6 percent, to $44.01. Hospira rose$. 15 or. 4 percent, to $36.18. Johnson& Johnson rose$. 15 or. 2 percent, to $88.16.
-
Drugmaker Pfizer Inc. has halted a late-stage study of an experimental cancer compound being tested in patients with a certain form of non-Hodgkin's lymphoma, because an interim analysis showed the drug wasn't helping patients live longer.
-
Bristol-Myers Squibb Co. rose$. 46 or 1.1 percent, to $43.76. Hospira rose$. 29 or. 8 percent, to $36.03. Johnson& Johnson fell$. 08 or. 1 percent, to $88.01.
-
May 20- Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it was not likely to improve survival.
-
NEW YORK-- A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. Advanced Micro Devices Inc. rose 2.3 percent to $4.17 with 18,890,700 shares traded. Bank of America Corp. rose. 9 percent to $13.56 with 53,010,700 shares traded.
-
Baxter International Inc. rose$. 80 or 1.1 percent, to $73.74. Bristol-Myers Squibb Co. rose$. 45 or 1.0 percent, to $43.75. Hospira rose$. 17 or. 5 percent, to $35.91.